• Fermentation-Derived Glucosamine for Joint Nutrition

    Non-Shellfish Manufacturing for Global Supplement Supply

    Embodies the essence of pure, high-quality dietary supplement ingredients

  • D-Glucosamine HCl

    Premium Joint Care Material

    D-Glucosamine Hcl powder, appearance, white powder

    D-Glucosamine Hcl

    Purecium D-Glucosamine HCl is a fermentation-derived glucosamine ingredient developed for global dietary supplement applications. Unlike conventional glucosamine produced through shellfish-shell hydrolysis, Purecium’s D-Glucosamine HCl uses a fermentation-based production approach, providing an alternative source for brands and manufacturers seeking non-shellfish glucosamine ingredients. Its defined chemical form makes it suitable for joint nutrition formulas, including capsules, tablets, powders and combination products. Purecium supports ingredient distributors, contract manufacturers, private-label supplement producers and finished-product brands with bulk supply, specification support and quality documentation. For customers developing modern joint-health supplements, fermentation-derived D-Glucosamine HCl offers a differentiated sourcing option for global markets.

    Product name: D-Glucosamine Hcl

    Molecular formula: C6H13NO5 HCl

    Starting material: Corn

    Grade: Food grade

    Heavy Metals: USP

    Pesticide residue: USP/EP

    Packing size: 25kg/drum

    D-Glucosamine Hcl

    D-Glucosamine Sulfate 2kcl

    N-Acetyl-D-Glucosamine

    CAS#: 66-84-2

    Molecular weight: 215.63 g/mol

    Source: Fermentation

    Specification: 99% Titration

    Country of origin: China

    Residual solvent: USP/EP

    Allergen free/Gluten-free/Non-GMO/Vegan/Non-Irradiation

    D-Glucosamine Hcl ISO, Kosher, halal, food safety certification

    D-Glucosamine HCl Introduction

    D-Glucosamine HCl — Fermentation-Derived Glucosamine for Dietary Supplements

    Purecium D-Glucosamine HCl is a fermentation-derived glucosamine hydrochloride ingredient designed for use in dietary supplements and joint nutrition formulations.

    Glucosamine is an amino sugar naturally associated with glycosaminoglycan and connective-tissue biology. In supplement products, glucosamine is commonly formulated as a standalone ingredient or combined with ingredients such as chondroitin sulfate, MSM, collagen or other joint-nutrition components.

    The key distinction of Purecium D-Glucosamine HCl is its fermentation-derived origin. Instead of relying on conventional glucosamine production through hydrolysis of shrimp, crab or other shellfish shells, Purecium’s D-Glucosamine HCl is produced through a fermentation-based process.

    This provides B2B customers with an alternative sourcing route when developing non-shellfish glucosamine supplements or when the origin and production technology of the raw material are important purchasing considerations.

    Purecium supplies D-Glucosamine HCl for global dietary supplement supply chains, serving ingredient distributors, contract manufacturers, private-label manufacturers and finished-product brands.

    Source and Specification

    Product: D-Glucosamine HCl
    Source: Fermentation-derived
    Production route: Fermentation-based, non-shellfish hydrolysis
    Application: Dietary supplement ingredient
    Typical dosage forms: Capsules, tablets, powders and combination formulations

    Final specification, assay, microbiological limits, heavy-metal limits, moisture, packaging and other release parameters should be confirmed against the current product specification and batch-specific Certificate of Analysis.

    Product Characteristics

    Fermentation-derived D-Glucosamine HCl provides several characteristics that are relevant to professional supplement manufacturers:

    • Fermentation-derived production route
    • Non-shellfish source positioning
    • Suitable for dietary supplement formulations
    • Compatible with joint nutrition product concepts
    • Suitable for standalone or combination formulas
    • Designed for professional bulk ingredient supply
    • Applicable to global B2B sourcing programs
    • Specification and batch documentation available according to customer requirements

    For manufacturers comparing glucosamine sources, the production route should be evaluated together with assay, purity, microbiological quality, residual impurities, allergen controls, consistency and documentation rather than by source description alone.

    Fermentation-Based Manufacturing

    Purecium D-Glucosamine HCl is produced through a controlled fermentation-based manufacturing route rather than conventional shellfish-shell hydrolysis.

    The general production concept involves controlled fermentation to generate the target glucosamine intermediate, followed by downstream processing, purification, conversion into the hydrochloride form where applicable, concentration, crystallization or related separation operations, drying and final quality control.

    The fermentation route provides a fundamentally different starting-material pathway from shellfish-derived glucosamine. For B2B customers, this distinction can be particularly relevant when developing products that require a non-shellfish source or when supply-chain teams need clearer traceability of the ingredient's origin.

    Manufacturing parameters are controlled throughout the process to support consistent product quality between batches. The finished ingredient is then tested against the applicable specification before release.

    Primary Applications

    Joint Nutrition Supplements

    Glucosamine is widely used in joint-health and mobility-oriented supplement formulations. Purecium D-Glucosamine HCl can be used as a core glucosamine ingredient in products positioned around joint nutrition and connective-tissue support.

    Capsules and Tablets

    D-Glucosamine HCl is suitable for conventional solid dosage formats, including capsules and tablets. It can be formulated as a single active ingredient or combined with complementary joint-nutrition ingredients.

    Powder Formulations

    Bulk D-Glucosamine HCl can also be incorporated into powder-based supplement products and customized nutritional blends.

    Combination Formulas

    Glucosamine is frequently formulated alongside ingredients such as chondroitin sulfate, MSM, collagen peptides and other ingredients used in joint-nutrition concepts. Formula developers should evaluate the final combination for dosage, stability, compatibility and regulatory requirements.

    Research Background and Biological Mechanism

    Glucosamine is a naturally occurring amino sugar involved in biochemical pathways associated with glycosaminoglycan production and extracellular-matrix biology. Because glycosaminoglycans are important components of cartilage and other connective tissues, glucosamine has been investigated extensively in the context of joint structure and osteoarthritis.

    Experimental research has proposed several mechanisms through which glucosamine may influence joint-related biology, including effects on extracellular-matrix metabolism, glycosaminoglycan synthesis and inflammatory signaling. However, mechanisms observed in biochemical, cellular or animal models should not automatically be interpreted as demonstrated clinical benefits in humans.

    For dietary supplement communication, the appropriate positioning is therefore joint nutrition and connective-tissue support, subject to the regulatory requirements of the target market.

    Clinical Research

    Glucosamine has been studied extensively in human clinical research, particularly in relation to osteoarthritis and joint symptoms. However, the evidence is not uniform.

    Research has evaluated different glucosamine forms, including glucosamine hydrochloride and glucosamine sulfate, and differences in formulation, dosage, study population and product characteristics make direct comparison difficult. Major evidence reviews have reported inconsistent outcomes, while some clinical guidelines have recommended against glucosamine for osteoarthritis because of insufficient or inconsistent evidence.

    For this reason, Purecium does not position D-Glucosamine HCl as a treatment for osteoarthritis. Instead, the ingredient is supplied as a raw material for dietary supplement manufacturers developing products positioned around joint and mobility nutrition.

    Production and Quality Control

    For B2B ingredient customers, quality control extends beyond the final assay value. Important quality considerations for D-Glucosamine HCl include:

    • Raw-material and fermentation-process control
    • Process consistency
    • Purification control
    • Final identity and assay
    • Moisture control
    • Microbiological testing
    • Heavy-metal testing
    • Residual impurity control
    • Batch-to-batch consistency
    • Packaging integrity
    • Storage and shelf-life evaluation
    • Batch-specific Certificate of Analysis

    Customers may also require additional documentation according to destination market, finished-product category and internal supplier-qualification procedures.

    B2B Supply and Global Support

    Purecium D-Glucosamine HCl is supplied as a professional dietary supplement ingredient rather than a finished consumer product.

    The ingredient is intended for:

    • Dietary supplement ingredient distributors
    • Contract manufacturers
    • Private-label supplement manufacturers
    • Finished-product brands
    • Joint-health and mobility nutrition brands
    • Global supplement formulators

    Purecium supports B2B customers with product specifications, quality documentation, bulk ingredient supply and application-oriented communication.

    For distributors, a fermentation-derived D-Glucosamine HCl provides a differentiated product story compared with conventional shellfish-derived glucosamine. For manufacturers and brands, it offers an alternative ingredient source for non-shellfish glucosamine formulations intended for global dietary supplement markets.

    Why Source D-Glucosamine HCl from Purecium?

    Purecium combines a fermentation-derived D-Glucosamine HCl source with B2B ingredient supply support for international dietary supplement customers.

    The key value proposition is not simply the glucosamine ingredient itself, but the combination of:

    Fermentation-derived source + non-shellfish positioning + defined glucosamine form + quality control + B2B supply support.

    This makes Purecium D-Glucosamine HCl a suitable sourcing option for distributors, contract manufacturers and supplement brands looking for a differentiated glucosamine ingredient for modern joint-nutrition products.

  • D-Glucosamine Hcl workshop
    D-Glucosamine Hcl packing room
    D-Glucosamine Hcl testing
    D-Glucosamine Hcl production
    D-Glucosamine Hcl factory
    D-Glucosamine Hcl workshop
    D-Glucosamine Hcl workshop
    D-Glucosamine Hcl production
    D-Glucosamine Hcl packing room
    D-Glucosamine Hcl testing
    D-Glucosamine Hcl factory
    D-Glucosamine Hcl workshop

  • D-Glucosamine HCl Frequently Asked Questions (FAQ) for B2B Buyers

    1. What makes Purecium D-Glucosamine HCl different from conventional glucosamine?

    Purecium D-Glucosamine HCl is produced through a fermentation-based manufacturing route rather than conventional hydrolysis of shrimp, crab or other shellfish shells. This gives the ingredient a differentiated source profile for supplement manufacturers that specifically want a non-shellfish glucosamine ingredient. For B2B buyers, the distinction is particularly relevant when source traceability, formulation positioning, allergen considerations or product-market requirements influence raw-material selection.

    2. Is Purecium D-Glucosamine HCl derived from shellfish?

    No. Purecium D-Glucosamine HCl is fermentation-derived and is not produced through hydrolysis of shrimp or crab shells. This makes its production route fundamentally different from traditional shellfish-derived glucosamine. However, customers should evaluate the supplier's complete allergen-control and manufacturing documentation when a finished product requires a specific shellfish-free or allergen-free claim in a particular market.

    3. Why are supplement manufacturers interested in fermentation-derived glucosamine?

    Fermentation-derived glucosamine gives manufacturers an alternative to shellfish-based sourcing. This can be useful for brands developing non-shellfish product concepts, expanding their consumer positioning, or seeking greater differentiation in the raw-material supply chain. It also allows procurement teams to evaluate glucosamine according to its production technology and source rather than treating all glucosamine ingredients as interchangeable.

    4. Can fermentation-derived D-Glucosamine HCl be used in joint-health supplements?

    Yes. D-Glucosamine HCl is commonly used as an ingredient in joint and mobility nutrition products. It can serve as a standalone glucosamine ingredient or be combined with other ingredients used in joint formulations, such as chondroitin sulfate, MSM or collagen. The appropriate finished-product positioning and claims depend on the regulatory requirements of the target market.

    5. Is glucosamine hydrochloride the same as glucosamine sulfate?

    No. Glucosamine hydrochloride and glucosamine sulfate are different salt forms of glucosamine and should not be treated as interchangeable when evaluating clinical evidence, formulation specifications or product labels. Human research has included both forms, but results cannot automatically be transferred from one form to another. Buyers should therefore specify the required salt form when sourcing a glucosamine ingredient.

    6. What should a buyer compare when sourcing fermentation-derived D-Glucosamine HCl?

    A professional buyer should compare the source and manufacturing route together with assay, identity, purity, microbiological quality, heavy metals, moisture, residual impurities, batch consistency, packaging, shelf life and documentation. It is also important to confirm whether the supplier can provide batch-specific COAs and supporting quality documents. For global supply, regulatory documentation and the suitability of the ingredient for the intended market should also be considered.

    7. How is fermentation-derived D-Glucosamine HCl manufactured?

    The manufacturing route begins with controlled fermentation rather than shellfish-shell hydrolysis. After fermentation, downstream processing is used to recover and purify the target glucosamine intermediate. Further processing is used to obtain the hydrochloride form, followed by concentration, separation or crystallization, drying and final quality testing. The exact industrial process parameters are controlled by the manufacturer and should be evaluated as part of supplier qualification.

    8. Does fermentation-derived glucosamine have the same chemical identity as shellfish-derived glucosamine?

    The production source and manufacturing route are different, but the relevant question for a finished ingredient is the identity and specification of the final glucosamine hydrochloride. Source therefore should not be confused with the final chemical form. B2B buyers should evaluate identity, assay, purity and impurity specifications alongside source documentation rather than assuming that two products are equivalent simply because both are called glucosamine HCl.

    9. What is the role of glucosamine in joint-related biological pathways?

    Glucosamine is an amino sugar involved in biochemical pathways associated with glycosaminoglycan and extracellular-matrix biology. Because cartilage contains proteoglycans and other extracellular-matrix components, glucosamine has been investigated in relation to cartilage metabolism and joint biology. Experimental studies have also examined effects on inflammatory and cellular signaling. These mechanisms provide a scientific basis for research interest but should not be interpreted as proof that a dietary supplement treats osteoarthritis.

    10. Is there clinical evidence supporting glucosamine for osteoarthritis?

    There is extensive human research on glucosamine, but the clinical evidence is inconsistent. Studies have evaluated different glucosamine preparations, including hydrochloride and sulfate forms, and results vary according to formulation, population and study design. Major evidence reviews have concluded that the overall evidence is uncertain or inconsistent, while some clinical guidelines recommend against glucosamine for osteoarthritis.

    For this reason, D-Glucosamine HCl should be described as a dietary supplement ingredient for joint and mobility nutrition rather than as a proven treatment for osteoarthritis.

    11. Can Purecium D-Glucosamine HCl be combined with chondroitin sulfate?

    Yes. Glucosamine and chondroitin are frequently combined in joint-nutrition formulations. From a formulation perspective, manufacturers should evaluate the dosage contribution, physical properties, compatibility, stability and final serving size of both ingredients. The clinical evidence for the combination is also not uniform, so finished-product claims should be developed according to the applicable regulatory framework rather than inferred solely from the presence of both ingredients.

    12. Is D-Glucosamine HCl suitable for capsules and tablets?

    Yes. D-Glucosamine HCl is well suited to conventional solid dosage forms such as capsules and tablets. Formulators should evaluate bulk density, flowability, particle characteristics, compression behavior and compatibility with excipients during product development. For high-dose glucosamine formulations, the serving size and physical space required in the final dosage form should also be considered during capsule or tablet design.

    13. What quality tests are important for fermentation-derived D-Glucosamine HCl?

    Important quality controls can include identity, assay, purity, moisture, microbiological parameters, heavy metals and other applicable impurity tests. For fermentation-derived materials, manufacturers should also maintain controls over the fermentation process and downstream purification. A reliable B2B supply program should support batch-specific testing and documentation so customers can verify that each shipment meets the agreed specification.

    14. Is fermentation-derived D-Glucosamine HCl suitable for global supplement brands?

    It can be suitable for global supplement development, but regulatory acceptance must always be evaluated market by market. The source, manufacturing process, ingredient specification, labeling requirements and permitted claims can differ between jurisdictions. Purecium positions fermentation-derived D-Glucosamine HCl as a bulk ingredient for international distributors, contract manufacturers, private-label producers and finished-product brands that need a non-shellfish glucosamine sourcing option.

    15. Why choose Purecium for fermentation-derived D-Glucosamine HCl?

    Purecium offers D-Glucosamine HCl with a fermentation-derived, non-shellfish production route for professional dietary supplement supply chains. The product is positioned for ingredient distributors, contract manufacturers, private-label manufacturers and finished-product brands seeking a differentiated glucosamine source. Purecium's B2B approach focuses on product specifications, quality documentation, bulk supply and customer-specific sourcing requirements, making the ingredient suitable for companies developing joint-nutrition and mobility-focused supplement products for global markets.

  • INQUIRY FORM

    Let's Discuss Your Needs

    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More